Evidence map›Paper›PMID 41811958›Full record

ArticleScience advances2026

Integrated reiterative pipeline for rapid epitope-based pan-alphavirus vaccines.

Alice F Versiani, Peter McCaffrey, Helder V Ribeiro-Filho, Natalia I O Silva, Paulo S Lopes-de-Oliveira, Jean-Paul Carrera, Mauricio L Nogueira, Rafael E Marques, Shannan L Rossi, Nikos Vasilakis

Abstract read
In one paragraph

Article in Science advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Alice F VersianiDepartment of Pathology, University of Texas Medical Branch, 301 University Blvd. Galveston, TX 77555-0609, USA.ORCID 0000-0003-1378-5380
Peter McCaffreyDepartment of Pathology, University of Texas Medical Branch, 301 University Blvd. Galveston, TX 77555-0609, USA.ORCID 0000-0002-4450-8143
Helder V Ribeiro-FilhoBrazilian Biosciences National Laboratory - LNBio, Brazilian Center for Research in Energy and Materials - CNPEM, Campinas 13083-100, SP, Brazil.ORCID 0000-0001-8471-207X
Natalia I O SilvaDepartment of Pathology, University of Texas Medical Branch, 301 University Blvd. Galveston, TX 77555-0609, USA.ORCID 0000-0003-3449-8313
Paulo S Lopes-de-OliveiraBrazilian Biosciences National Laboratory - LNBio, Brazilian Center for Research in Energy and Materials - CNPEM, Campinas 13083-100, SP, Brazil.ORCID 0000-0002-1287-8019
Jean-Paul CarreraDepartment of Research in Virology and Biotechnology, Gorgas Memorial Institute of Health Studies, Panama City, Panama.ORCID 0000-0002-1459-2858
Mauricio L NogueiraDepartment of Pathology, University of Texas Medical Branch, 301 University Blvd. Galveston, TX 77555-0609, USA.ORCID 0000-0003-1102-2419
Rafael E MarquesBrazilian Biosciences National Laboratory - LNBio, Brazilian Center for Research in Energy and Materials - CNPEM, Campinas 13083-100, SP, Brazil.ORCID 0000-0002-6949-0947
Shannan L RossiDepartment of Pathology, University of Texas Medical Branch, 301 University Blvd. Galveston, TX 77555-0609, USA.ORCID 0000-0003-2450-2374
Nikos VasilakisDepartment of Pathology, University of Texas Medical Branch, 301 University Blvd. Galveston, TX 77555-0609, USA.ORCID 0000-0002-0708-3289

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The vast diversity of the virosphere underscores the need for rapid, adaptable vaccine development infrastructures. Arthropod-borne zoonotic alphaviruses, in particular, continue to pose substantial threats to human and animal health. We present a fast, multitarget vaccine design pipeline integrating machine learning-based epitope prediction, protein modeling, and docking to prioritize viral peptides by immunogenicity, allele coverage, solubility, and stability. T cell epitopes were validated using peptide microarrays and molecular dynamics simulations, confirming receptor binding accuracy. Flow cytometry of murine and human peripheral blood mononuclear cells demonstrated robust T cell activation and cytokine secretion (IFN-γ, TNF-α, or IL-2), dependent on species and HLA allele. Final candidates were selected by composite immunogenicity scores. While this study primarily validates the T cell-specific arm of our predictive pipeline, complementary B cell epitope analyses are ongoing. Our findings support the development of broadly protective pan-alphaviral vaccines and the establishment of efficient, tunable processes for global vaccine development.

Indexed as

AlphavirusEpitopesEpitopes, B-LymphocyteEpitopes, T-LymphocyteViral VaccinesAnimalsHumansImmunoinformaticsLeukocytes, MononuclearMiceProtein Subunit VaccinesEpitopesEpitopes, B-LymphocyteEpitopes, T-LymphocyteProtein Subunit VaccinesViral Vaccines

Identifiers

PMID41811958
PMCPMC12978219

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.